Delivery Order SPE2DR25D2100-SPE2DR26FA0GM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,040.22. The delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive, competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $2,357.53. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) with a ceiling value of $12,875.39. The contract was issued on November 14, 2025, with an ultimate completion date of November 17, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's larger pharmaceutical supply framework with the federal government....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on August 20, 2025, with a ceiling value of $4,312.01 and a firm fixed price structure. This non-set-aside delivery order is expected to be completed by August 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,163.95. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order is set for ultimate completion on October 23, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,082.68 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed price contract valued at $11,828.08. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units) under a firm fixed price contract valued at $5,928.56, with an ultimate completion date of October 30, 2025. This non-set-aside award was made on October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitively awarded transaction that supplies...
- The Defense Logistics Agency awarded a $24,894.40 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Progesterone 100 mg capsules (100-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units) valued at $1,083.44. This competitively awarded, firm fixed-price delivery order was established on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0GMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $6,740.47. The award, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical requirements through competitive contracting, combined with its extensive portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, positions the company as a primary vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 11/24/25 |